The FDA announced yesterday that is has approved Anoro Ellipta (umeclidinium and vilanterol inhalation powder) for the once-daily, long-term maintenance treatment of airflow obstruction in ...

Its dry powder inhaler tech, which boasts enhanced product stability and increased lung penetration of drug particles, is behind its three licensed inhalers Anoro Ellipta, Relvar Ellipta and ...